Published in Blood Weekly, December 23rd, 2010
After robust feedback from physicians, clients, researchers and expecting parents during the past year, StemCyte reconstructed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.